TrialClinical rheumatology2018

Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

J A Walsh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.